Parabolic Flight
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance (NCT05852730) | Repurposed Therapeutics, Inc. | 2021-08-10 |
Track Parabolic Flight automatically
Every clearance here is in the API, with alerts when new ones post.